Translational Technologies International (TTI) announced the acquisition of Asheville, NC-based Decision Driver Analytics (DDA). DDA provides the full range of health economics, outcomes research and market access solutions to medical device, biotechnology, and pharmaceutical manufacturers as well as additional value analysis services to both healthcare providers and payors. TTI’s combination with DDA marks a 25% increase in TTI staff and a projected 50% increase in growth in TTI’s commercial business. TTI will maintain the Asheville, NC office.
Dr. April Zambelli-Weiner, TTI President and CEO stated: “DDA has been a trusted partner for many years and the acquisition was a natural evolution for our teams. Our combined capabilities under a unified brand and infrastructure will allow us to not only better serve our current clients but to expand our service offerings, opening doors to new clients and projects.”
The DDA team, led by Dr. Elizabeth Brooks, will head TTI’s commercial vertical, focused on a range of market access services, including health economic and disease modeling, clinical and epidemiological study design and execution, strategic market access planning and tactical implementation, and reimbursement support services .
The combined team will offer comprehensive value analysis, epidemiology including: predictive value analysis for improved product decision-making; clinical-economic study design and implementation; chronic disease modeling; burden of illness analyses; cost-effectiveness modeling; ROI analyses; administrative database analyses; survey and other formative research.
Dr. Brooks, the current President of DDA will be assuming the role of Executive Vice President of Health Economics and Outcomes Research and plans to quickly roll out the expanded capabilities of the team: “We couldn’t have asked for better circumstances for our team. Our current client projects will continue without interruption utilizing existing DDA staff. What we’re most excited about, though, is the opportunity to better support the success of our current and future clients through our newly expanded service offerings and capacity.”
Dr. Zambelli-Weiner added: “At TTI we believe our success is rooted in our exceptional commitment to quality, our ethics, and our culture of service. These are intangibles that we value highly and that have similarly flourished under Dr. Brooks’ leadership at DDA. It’s an honor to be able to bring these groups of world class, like-minded professionals together. When you realize this kind of synergy there’s no limit to what can be achieved.”
Learn more about DDA here.